Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
9m agoCreating America’s First Transcontinental Railroad: Union Pacific and Norfolk Southern’s Amended STB Merger Application Estimates Shippers Will Save $3.5 Billion Annually
9m agoMarcus Corporation Reports First Quarter Fiscal 2026 Results
10m agoIntercontinental Exchange Approves Second Quarter Dividend of $0.52 per Share
10m agoLincoln Electric Reports First Quarter 2026 Results
10m agoDragonfly Energy to Report First Quarter 2026 Financial and Operational Results on May 14, 2026
Incyte Corporation logo

Incyte Corporation

About

Incyte Corporation (NASDAQ:INCY) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 28 2026
Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates
Apr 2 2026
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Mar 28 2026
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Mar 25 2026
Incyte Announces Executive Leadership Appointments
Mar 20 2026
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting

Financials

Revenue
$5.14 B
Market Cap
$19.09 B
P/E Ratio
14.97
EPS
6.41

Community Chat

Ask AI

6ix6ixAIEvents